Back to Journals » OncoTargets and Therapy » Volume 13
RETRACTED ARTICLE: The lncRNA LINC01194/miR-486-5p Axis Facilitates Malignancy in Non-Small Cell Lung Cancer via Regulating CDK4
Authors Xing Z, Zhang Z, Gao Y, Zhang X, Kong X, Zhang J, Bai H
Received 17 October 2019
Accepted for publication 17 February 2020
Published 15 April 2020 Volume 2020:13 Pages 3151—3163
DOI https://doi.org/10.2147/OTT.S235037
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr William C. Cho
This paper has been retracted.
Xing Z, Zhang Z, Gao Y, et al. Onco Targets Ther. 2020;13:3151–3163.
We, the Editors and Publisher of OncoTargets and Therapy, have retracted the following article.
Following publication of the article, concerns were raised about the duplication of images from Figure 3 with images from other unrelated articles. Specifically,
- Images for Figure 3B have been duplicated with images for Figure 2C from Zhao C, Li Y, Hu X, et al. LncRNA HCP5 Promotes Cell Invasion and Migration by Sponging miR-29b-3p in Human Bladder Cancer. Onco Targets Ther. 2020;13:11827-11838. https://doi.org/10.2147/OTT.S249770 and Figure 3H from Peng Y, Li X, Liu H, et al. RETRACTED ARTICLE: microRNA-18a from M2 Macrophages Inhibits TGFBR3 to Promote Nasopharyngeal Carcinoma Progression and Tumor Growth via TGF-β Signaling Pathway. Nanoscale Res Lett. 2020;15:196. https://doi.org/10.1186/s11671-020-03416-8.
The authors did not respond to our queries and were unable to provide an explanation for the duplicated images or provide data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were notified of this.
We have been informed in our decision-making by our editorial policies and COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.